Showing results (181-190 of 317) with videos related to

Sort By:
Pageof 32
Acta Gastro-Enterologica Belgica|May 1, 2009
Quality assurance and recommendations for quality assessment of screening colonoscopy in BelgiumE Macken, T Moreels, P Pelckmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2014
Quality assurance in the treatment of colorectal cancer: the EURECCA initiativeA J Breugom, P G Boelens, C B M van den Broek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2017
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trialsD Arnold, B Lueza, J-Y Douillard, et al.
Texas Heart Institute Journal|July 17, 2001
Supernormal left ventricular diastolic function in triathletesP J Claessens, C W Claessens, M M Claessens, et al.
European Journal of Clinical Nutrition|September 14, 2007
The effect of different protein hydrolysate/carbohydrate mixtures on postprandial glucagon and insulin responses in healthy subjectsM Claessens, W Calame, A D Siemensma, et al.
European Geriatric Medicine|August 3, 2023
Comparison of different prognostic scores in estimating short- and long-term mortality in COVID-19 patients above 60 years old in a university hospital in BelgiumC Van Hauwermeiren, M Claessens, M Berland, et al.
ESMO Open|June 10, 2022
Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysisT Yoshino, E Van Cutsem, J Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancerP Flamen, E Van Cutsem, A Lerut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2015
A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patientsE Van Cutsem, H Prenen, G D'Haens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation studyR K Kelley, C Verslype, A L Cohn, et al.
Pageof 32